-
1دورية أكاديمية
المؤلفون: Spoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, Edward Banham-Hall, Simon Bond, Elena Hernan-Sancho, Sam Norton, Joseph Cheriyan, Andrew Cope, James Galloway, Frances Hall, David Jayne, Ian B. Wilkinson
المصدر: Trials, Vol 21, Iss 1, Pp 1-3 (2020)
مصطلحات موضوعية: COVID-19, Randomised controlled trial, Protocol, Baricitinib, Ravulizumab, Open-label, Medicine (General), R5-920
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Paul J Cacciottolo, Michalis S Kostapanos, Elena Hernan Sancho, Fotini Kaloyirou, Evangelia Vamvaka, Joanna Helmy, Annette Hubsch
المصدر: BMJ Open, Vol 11, Iss 4 (2021)
مصطلحات موضوعية: Medicine
وصف الملف: electronic resource
-
3
المؤلفون: Michalis Kostapanos, Elena Hernan Sancho, Carmel M. McEniery, Joseph Cheriyan, Ian B. Wilkinson, Joanna Helmy, Fotini Kaloyirou, Holly Pavey, Evangelia Vamvaka, Paul J. Cacciottolo, Annette Hubsch
المصدر: BMJ Open, Vol 11, Iss 4 (2021)
BMJ Openمصطلحات موضوعية: medicine.medical_specialty, Statin, medicine.drug_class, Disease, Cardiovascular Medicine, Systemic inflammation, Antibodies, Monoclonal, Humanized, preventive medicine, Ezetimibe, Internal medicine, Positron Emission Tomography Computed Tomography, medicine, lipid disorders, Humans, cardiovascular imaging, Preventive healthcare, Alirocumab, Randomized Controlled Trials as Topic, Wales, business.industry, PCSK9, Antibodies, Monoclonal, General Medicine, Cholesterol, LDL, Cardiovascular Diseases, cardiology, Good clinical practice, Medicine, medicine.symptom, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Proprotein Convertase 9, business, medicine.drug
-
4
المؤلفون: Joseph Cheriyan, Elena Hernan-Sancho, Frances Hall, Marie Fisk, James Galloway, Spoorthy Kulkarni, Michalis Kostapanos, Sam Norton, David Jayne, Edward Banham-Hall, Andrew P. Cope, Ian B. Wilkinson, Simon Bond
المساهمون: Kulkarni, Spoorthy [0000-0003-0598-9834], Apollo - University of Cambridge Repository
المصدر: Trials
Trials, Vol 21, Iss 1, Pp 1-3 (2020)مصطلحات موضوعية: medicine.medical_specialty, Letter, Active Comparator, medicine.medical_treatment, Pneumonia, Viral, Medicine (miscellaneous), Antibodies, Monoclonal, Humanized, law.invention, Adaptive trial, Betacoronavirus, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Baricitinib, law, Internal medicine, Protocol, Humans, Immunologic Factors, Medicine, Data monitoring committee, Pharmacology (medical), Open-label, 030212 general & internal medicine, Dosing, Pandemics, Randomized Controlled Trials as Topic, Mechanical ventilation, Randomised controlled trial, Sulfonamides, lcsh:R5-920, SARS-CoV-2, business.industry, Ravulizumab, Incidence (epidemiology), Drug Repositioning, COVID-19, COVID-19 Drug Treatment, Clinical trial, Intensive Care Units, Purines, Repurposed drugs, Inclusion and exclusion criteria, Azetidines, Pyrazoles, Coronavirus Infections, lcsh:Medicine (General), business, 030217 neurology & neurosurgery
وصف الملف: application/pdf
-
5
المؤلفون: Paul J. Cacciottolo, Joseph Cheriyan, Elena Hernan Sancho, Kaisa M. Mäki-Petäjä, Evangelia Vamvaka, Fotini Kaloyirou, Annette Hubsch, Joanna Helmy, Ian B. Wilkinson, Michalis Kostapanos, Holly Pavey
المصدر: Journal of the American College of Cardiology. 77:159
مصطلحات موضوعية: Ezetimibe, business.industry, Vascular inflammation, Medicine, Pharmacology, Cardiology and Cardiovascular Medicine, business, Alirocumab, medicine.drug